ascites: occur in ovarian cancer

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents finding
Weight: 0.40
, complication
Weight: 0.32
Siblings pulmonary edema
Weight: 0.29
, pleural effusion
Weight: 0.29
, myocardial infarction
Weight: 0.29
, pneumothorax
Weight: 0.28
, pyelonephritis
Weight: 0.28

Related properties

Property Similarity
occur in ovarian cancer 1.00
be in ovarian cancer 0.98
occur in cancer 0.89
occur in lung cancer 0.87
occur in cancer patients 0.85
occur in liver disease 0.85
be to cancer 0.84
be for cancer 0.84
develop in liver disease 0.81
be for cancer difficult 0.80

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.10
Rule weight: 0.13
Evidence weight: 0.90
Similarity weight: 0.87
Evidence: 0.28
¬ Remarkable(ascites, occur in ovarian cancer) ⋁
Evidence: 0.37
¬ Remarkable(pleural effusion, occur in lung cancer)

Remarkability from sibling implausibility

0.46
Rule weight: 0.60
Evidence weight: 0.88
Similarity weight: 0.87
Evidence: 0.61
Plausible(ascites, occur in ovarian cancer) ⋁
Evidence: 0.37
Remarkable(pleural effusion, occur in lung cancer) ⋁
Evidence: 0.48
¬ Plausible(pleural effusion, occur in lung cancer)

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.80
Similarity weight: 1.00
Evidence: 0.61
Plausible(ascites, occur in ovarian cancer) ⋁
Evidence: 0.50
¬ Salient(ascites, occur in ovarian cancer)

Similarity expansion

0.73
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.98
Evidence: 0.81
Typical(ascites, occur in ovarian cancer) ⋁
Evidence: 0.67
¬ Typical(ascites, be in ovarian cancer)
0.71
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.98
Evidence: 0.50
Salient(ascites, occur in ovarian cancer) ⋁
Evidence: 0.31
¬ Salient(ascites, be in ovarian cancer)
0.70
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.98
Evidence: 0.28
Remarkable(ascites, occur in ovarian cancer) ⋁
Evidence: 0.23
¬ Remarkable(ascites, be in ovarian cancer)
0.70
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.98
Evidence: 0.61
Plausible(ascites, occur in ovarian cancer) ⋁
Evidence: 0.43
¬ Plausible(ascites, be in ovarian cancer)
0.70
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.85
Evidence: 0.81
Typical(ascites, occur in ovarian cancer) ⋁
Evidence: 0.20
¬ Typical(ascites, occur in liver disease)
0.69
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.89
Evidence: 0.81
Typical(ascites, occur in ovarian cancer) ⋁
Evidence: 0.49
¬ Typical(ascites, occur in cancer)
0.66
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.89
Evidence: 0.61
Plausible(ascites, occur in ovarian cancer) ⋁
Evidence: 0.33
¬ Plausible(ascites, occur in cancer)
0.65
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.89
Evidence: 0.50
Salient(ascites, occur in ovarian cancer) ⋁
Evidence: 0.28
¬ Salient(ascites, occur in cancer)
0.64
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.85
Evidence: 0.61
Plausible(ascites, occur in ovarian cancer) ⋁
Evidence: 0.28
¬ Plausible(ascites, occur in liver disease)
0.63
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.81
Evidence: 0.81
Typical(ascites, occur in ovarian cancer) ⋁
Evidence: 0.49
¬ Typical(ascites, develop in liver disease)
0.61
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.85
Evidence: 0.81
Typical(ascites, occur in ovarian cancer) ⋁
Evidence: 0.82
¬ Typical(ascites, occur in cancer patients)
0.60
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.81
Evidence: 0.61
Plausible(ascites, occur in ovarian cancer) ⋁
Evidence: 0.35
¬ Plausible(ascites, develop in liver disease)
0.60
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.89
Evidence: 0.28
Remarkable(ascites, occur in ovarian cancer) ⋁
Evidence: 0.30
¬ Remarkable(ascites, occur in cancer)
0.59
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.81
Evidence: 0.50
Salient(ascites, occur in ovarian cancer) ⋁
Evidence: 0.30
¬ Salient(ascites, develop in liver disease)
0.58
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.85
Evidence: 0.50
Salient(ascites, occur in ovarian cancer) ⋁
Evidence: 0.39
¬ Salient(ascites, occur in liver disease)
0.56
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.85
Evidence: 0.28
Remarkable(ascites, occur in ovarian cancer) ⋁
Evidence: 0.33
¬ Remarkable(ascites, occur in cancer patients)
0.54
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.85
Evidence: 0.61
Plausible(ascites, occur in ovarian cancer) ⋁
Evidence: 0.64
¬ Plausible(ascites, occur in cancer patients)
0.53
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.81
Evidence: 0.28
Remarkable(ascites, occur in ovarian cancer) ⋁
Evidence: 0.33
¬ Remarkable(ascites, develop in liver disease)
0.52
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.85
Evidence: 0.50
Salient(ascites, occur in ovarian cancer) ⋁
Evidence: 0.58
¬ Salient(ascites, occur in cancer patients)
0.33
Rule weight: 0.85
Evidence weight: 0.46
Similarity weight: 0.85
Evidence: 0.28
Remarkable(ascites, occur in ovarian cancer) ⋁
Evidence: 0.76
¬ Remarkable(ascites, occur in liver disease)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.50
Salient(ascites, occur in ovarian cancer) ⋁
Evidence: 0.81
¬ Typical(ascites, occur in ovarian cancer) ⋁
Evidence: 0.28
¬ Remarkable(ascites, occur in ovarian cancer)

Typical implies Plausible

0.33
Rule weight: 0.48
Evidence weight: 0.68
Similarity weight: 1.00
Evidence: 0.61
Plausible(ascites, occur in ovarian cancer) ⋁
Evidence: 0.81
¬ Typical(ascites, occur in ovarian cancer)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.82
Similarity weight: 0.87
Evidence: 0.28
¬ Remarkable(ascites, occur in ovarian cancer) ⋁
Evidence: 0.62
¬ Typical(pleural effusion, occur in lung cancer)